Medicenna Therapeutics Corp.
MDNAF
$0.70
-$0.0212-2.94%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 26.54% | 18.61% | 16.40% | -49.49% | -38.32% |
Total Receivables | 224.97% | 386.30% | 38.11% | 36.03% | 130.69% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -48.55% | -54.46% | 4.69% | -51.90% | -39.61% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 26.59% | 18.21% | 16.59% | -47.61% | -37.59% |
|
|||||
Total Current Assets | 26.59% | 18.21% | 16.59% | -47.61% | -37.59% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -16.17% | -8.26% | -11.26% | -6.65% | -4.15% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 27.17% | 18.85% | 16.62% | -47.54% | -37.53% |
|
|||||
Total Accounts Payable | -57.14% | -46.12% | 5.76% | 27.91% | 38.03% |
Total Accrued Expenses | -- | -- | -- | -63.70% | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | 661.39% | 250.35% | -67.95% |
Total Other Current Liabilities | -- | -- | 661.39% | 250.35% | -67.95% |
Total Current Liabilities | -37.20% | -22.33% | 215.37% | 100.17% | -3.94% |
|
|||||
Total Current Liabilities | -37.20% | -22.33% | 215.37% | 100.17% | -3.94% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | 1,516.94% | -- | -- | -- |
Total Liabilities | 192.59% | 199.45% | 215.37% | 100.17% | -3.94% |
|
|||||
Common Stock & APIC | 4.90% | 12.32% | 7.58% | 1.01% | 3.33% |
Retained Earnings | -18.46% | -30.64% | -27.03% | -31.34% | -22.97% |
Treasury Stock & Other | 22,546.20% | 32,643.24% | 25,755.56% | -66.75% | -69.39% |
Total Common Equity | -14.02% | -14.33% | -17.70% | -82.41% | -42.54% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -14.02% | -14.33% | -17.70% | -82.41% | -42.54% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -14.02% | -14.33% | -17.70% | -82.41% | -42.54% |
|